Organic & Biomolecular Chemistry
Communication
more potent in comparison to the original unsubstituted 15b,
as it still showed good stimulatory activity at the concentration
of 1.0 × 10−9 M L−1, which was superior to that of 15b.
C. A. Beveridge, C. Rameau and S. F. Rochange, Nature,
2008, 455, 189; (d) S. Al-Babili and H. J. Bouwmeester,
Annu. Rev. Plant Biol., 2015, 66, 161; (e) M. T. Waters,
C. Gutjahr, T. Bennett and D. C. Nelson, Annu. Rev. Plant
Biol., 2017, 68, 291.
4 For other bioactivities on strigolactone analogues, see:
(a) J. Zheng, Y. Han, J. Wang, H. Yang, H. Kong, K. Liu,
S. Chen, Y. Chen, Y. Chang, W. Chen, J. Guo and P. Sun,
MedChemComm, 2018, 9, 181; (b) C. B. Pollock, H. Koltai,
Y. Kapulnik, C. Prandi and R. I. Yarden, Breast Cancer Res.
Treat., 2012, 134, 1041.
5 For the discovery of GR-24, see: (a) A. W. Johnson,
G. Gowda, A. Hassanali, J. Knox, S. Monaco, Z. Razavi and
G. Rosebery, J. Chem. Soc., Perkin Trans. 1, 1981, 1734. For
the development of GR-24, see: (b) M. Lachia, H. C. Wolf
and A. D. Mesmaeker, Bioorg. Med. Chem. Lett., 2014, 24,
2123; (c) H. Malik, F. P. J. T. Rutjes and B. Zwanenburg,
Tetrahedron, 2010, 66, 7198; (d) M. Lachia, P. M. J. Jung and
A. D. Mesmaeker, Tetrahedron Lett., 2012, 53, 4514;
(e) M. Yasui, A. Yamada, C. Tsukano, A. Hamza, I. Pápai
and Y. Takemoto, Angew. Chem., 2020, 59, 13479.
In conclusion, we have established a modular and concise
synthetic route to acquire the benzene-decorated 2nd generation
of strigolactams and GR-24, and it also represents an alternative
synthetic method to prepare the recently developed novel strigo-
lactam. The inexpensive commercially available substituted
N-Boc phenylalanines and O-pivalate phenyllactic acids were
employed as the starting materials, which underwent two key
transformations, the carboxylate directed ortho-selective olefina-
tion followed by decarboxylative Giese radical addition, to assem-
ble the A/B ring subunit. Preliminary biological activity evalu-
ation indicated that it is very necessary to modify the benzene
ring of the original strigolactam analogue, as we found that the
2nd generation strigolactam with methoxy substitution 15f was
more potent than the unsubstituted one. The preparation of
other strigolactam analogues and further studies on the struc-
ture–activity relationship are underway in our laboratory.
Conflicts of interest
6 For selected examples of the synthesis of stigolactams, see:
(a) M. Lachia, H. C. Wolf, P. J. M. Jung, C. Screpanti and
A. D. Mesmaeker, Bioorg. Med. Chem. Lett., 2015, 25, 2184;
(b) K. Ashida, Y. Hoshimoto, N. Tohnai, D. E. Scott,
M. Ohashi, H. Imaizumi, Y. Tsuchiya and S. Ogoshi, J. Am.
Chem. Soc., 2020, 142, 1594.
There are no conflicts to declare.
Acknowledgements
7 (a) Syngenta Participations AG, WO. Pat, 175025, 2019;
(b) Syngenta Participations AG, WO. Pat, 145979, 2018.
8 For selected reviews on the application of C–H functionali-
zation in the synthesis of natural products and drug mole-
cules, see: (a) J. Yamaguchi, A. D. Yamaguchi and K. Itami,
Angew. Chem., Int. Ed., 2012, 51, 8960; (b) D. J. Abrams,
P. A. Provencher and E. J. Sorensen, Chem. Soc. Rev., 2018,
47, 8925.
This work is supported by the National Natural Science
Foundation of China (NSFC) (Grant No. 22001165 and
21801075), the “Agri-X” Fund of Shanghai Jiao Tong University
(SJTU) (AF1500088/004) and the startup funding from SJTU.
We thank Prof. Yongqing Ma (Northwest Agriculture & Forestry
University) for supplying Orobanche aegyptiaca seeds. We
thank Prof. Zixing Li and Dr Yajie Li (SJTU) for their kind
assistance in biological activity testing.
9 Y. Ge, H. Wang, H.-N. Wang, S.-S. Yu, R. Yang, X. Chen,
Q. Zhao and G. Chen, Org. Lett., 2021, 23, 370.
10 For selected examples of Pd-catalyzed CO2H-directed C–H
functionalizations, see: (a) N. Dastbaravardeh, T. Toba,
M. E. Farmer and J.-Q. Yu, J. Am. Chem. Soc., 2015, 137,
9877; (b) K.-J. Xiao, L. Chu and J.-Q. Yu, Angew. Chem., Int.
Ed., 2016, 55, 2856; (c) D.-H. Wang, K. M. Engle, B.-F. Shi
and J.-Q. Yu, Science, 2010, 327, 315; (d) K. M. Engle,
D.-H. Wang and J.-Q. Yu, Angew. Chem., Int. Ed., 2010, 49,
6169; (e) K. K. Ghosh, A. Uttry, A. Mondal, F. Ghiringhelli,
P. Wedi and M. V. Gemmeren, Angew. Chem., 2020, 59,
12848; (f) Y. Zhu, X. Chen, C. Yuan, G. Li, J. Zhang and
Y. Zhao, Nat. Commun., 2017, 8, 14904; (g) K. K. Ghosh and
M. V. Gemmeren, Chem. – Eur. J., 2017, 23, 17697;
(h) T.-S. Mei, R. Giri, N. Maugel and J.-Q. Yu, Angew. Chem.,
Int. Ed., 2008, 47, 5215; (i) Y.-H. Zhang, B.-F. Shi and
J.-Q. Yu, Angew. Chem., Int. Ed., 2009, 48, 6097; ( j) G. Chen,
Z. Zhuang, G.-C. Li, T. G. Saint-Denis, Y. Hsiao, C. L. Joe
and J.-Q. Yu, Angew. Chem., Int. Ed., 2017, 56, 1506;
(k) F. Ghiringhelli, A. Uttry, K. K. Ghosh and
M. V. Gemmeren, Angew. Chem., 2020, 59, 23127;
Notes and references
1 For recent reviews on strigolactone and its analogues, see:
(a) A. D. Mesmaeker, C. Screpanti, R. Fonné-Pfister,
M. Lachia, A. Lumbroso and H. Bouwmeester, Chimia,
2019, 73, 549; (b) L. J. Bromhead and C. S. P. McErlean,
Eur. J. Org. Chem., 2017, 5712; (c) S. Al-Babili and
H. J. Bouwmeester, Annu. Rev. Plant Biol., 2015, 66, 161.
2 C. E. Cook, L. P. Whichard, B. Turner, M. E. Wall and
G. H. Egley, Science, 1966, 154, 1189.
3 For the bioactivity of strigolactone and its analogues in
plants, see: (a) K. Akiyama, K.-I. Matsuzaki and H. Hayashi,
Nature, 2005, 435, 824; (b) M. Umehara, A. Hanada,
S. Yoshida, K. Akiyama, T. Arite, N. Takeda-Kamiya,
H. Magome, Y. Kamiya, K. Shirasu, K. Yoneyama,
J. Kyozuka and S. Yamaguchi, Nature, 2008, 455, 195;
(c) V. Gomez-Roldan, S. Fermas, P. B. Brewer, V. Puech-
Pages, E. A. Dun, J.-P. Pillot, F. Letisse, R. Matusova,
S. Danoun, J.-C. Portais, H. Bouwmeester, G. Becard,
This journal is © The Royal Society of Chemistry 2021
Org. Biomol. Chem., 2021, 19, 7141–7146 | 7145